OBJECTIVES: Cohort studies are often used as a national surveillance tool to monitor trends in HIV treatment and morbidity outcomes. However, there are limited studies validating the accuracy of using cohorts as a representation of the overall HIV-positive population. We compared data from a large Australian HIV-positive cohort study (Australian HIV Observational Database [AHOD]) and a 10% longitudinal sample from Australia's subsidized prescription medication scheme (Pharmaceutical Benefits Scheme [PBS]) to assess the use of cohorts for providing representative data for surveillance and monitoring purposes. STUDY DESIGN AND SETTING: Basic demographics and treatment information from July 1, 2013, to March 31, 2016, were divided into half-yearly periods to compare HIV trends between AHOD (n = 2,488) and PBS (n = 18,409) patients. RESULTS: In both data sets, most patients were men, aged above 50 years, and primarily resided in New South Wales. Both data sets revealed a significant shift toward the increased use of integrase strand transfer inhibitors and a gradual decline in the use of protease inhibitors and nonnucleoside reverse-transcriptase inhibitors among the treated population in Australia. Similarly, a substantial increase in the use of once daily, single-tablet, fixed-dose combination regimens was also observed. CONCLUSION: Our results show that observational cohort studies can serve as useful surrogate surveillance tools for monitoring patient characteristics and HIV treatment trends.
OBJECTIVES: Cohort studies are often used as a national surveillance tool to monitor trends in HIV treatment and morbidity outcomes. However, there are limited studies validating the accuracy of using cohorts as a representation of the overall HIV-positive population. We compared data from a large Australian HIV-positive cohort study (Australian HIV Observational Database [AHOD]) and a 10% longitudinal sample from Australia's subsidized prescription medication scheme (Pharmaceutical Benefits Scheme [PBS]) to assess the use of cohorts for providing representative data for surveillance and monitoring purposes. STUDY DESIGN AND SETTING: Basic demographics and treatment information from July 1, 2013, to March 31, 2016, were divided into half-yearly periods to compare HIV trends between AHOD (n = 2,488) and PBS (n = 18,409) patients. RESULTS: In both data sets, most patients were men, aged above 50 years, and primarily resided in New South Wales. Both data sets revealed a significant shift toward the increased use of integrase strand transfer inhibitors and a gradual decline in the use of protease inhibitors and nonnucleoside reverse-transcriptase inhibitors among the treated population in Australia. Similarly, a substantial increase in the use of once daily, single-tablet, fixed-dose combination regimens was also observed. CONCLUSION: Our results show that observational cohort studies can serve as useful surrogate surveillance tools for monitoring patient characteristics and HIV treatment trends.
Authors: Sean B Rourke; Sandra Gardner; Ann N Burchell; Janet Raboud; Sergio Rueda; Ahmed M Bayoumi; Mona Loutfy; Curtis Cooper; Marek Smieja; Darien Taylor; Tony DiPede; Wendy Wobeser; Carol Major; Virginia Waring; Mark Fisher; John Cairney; Nicole Mittmann; Irving E Salit; Fred Crouzat; Kevin Gough; Edward Ralph; Roger Sandre; Don Kilby; Anita Rachlis Journal: Int J Epidemiol Date: 2012-02-16 Impact factor: 7.196
Authors: Nicole L De La Mata; Limin Mao; John De Wit; Don Smith; Martin Holt; Garrett Prestage; David P Wilson; Kathy Petoumenos Journal: Sex Health Date: 2015-10 Impact factor: 2.706
Authors: Hamish McManus; Jennifer F Hoy; Ian Woolley; Mark A Boyd; Mark D Kelly; Brian Mulhall; Norman J Roth; Kathy Petoumenos; Matthew G Law Journal: Antivir Ther Date: 2014-04-04
Authors: Stephen T Wright; Matthew G Law; David A Cooper; Phillip Keen; Ann McDonald; Melanie Middleton; Ian Woolley; Mark Kelly; Kathy Petoumenos Journal: J Int AIDS Soc Date: 2015-04-10 Impact factor: 5.396
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586